Trials / Not Yet Recruiting
Not Yet RecruitingNCT06607900
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
A Multi-center, Open, Single-arm, Basket-design Clinical Trial to Evaluate the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles hUC-MSC-sEV-001 Nasal Drops for the Treatment of Multiple Neurodegenerative Diseases
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and preliminary efficacy of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles hUC-MSC-sEV-001 nasal drops in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia, frontotemporal dementia, and amyotrophic lateral sclerosis.
Conditions
- Alzheimer Disease
- Parkinson Disease
- Lewy Body Dementia
- Multiple System Atrophy
- Fronto-temporal Dementia
- Amyotrophic Lateral Sclerosis
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hUC-MSC-sEV-001 nasal drops | hUC-MSC-sEV-001 nasal drops |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2027-08-31
- Completion
- 2028-08-31
- First posted
- 2024-09-23
- Last updated
- 2025-07-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06607900. Inclusion in this directory is not an endorsement.